Clinical Trials Related to Dexamethasone

Related studies linked through entity extraction aliases.

A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma

Status: RECRUITING
Phase: PHASE1/PHASE2

Baricitinib in Hospitalized Covid-19 Patients With Diabetes Mellitus

Status: WITHDRAWN
Phase: PHASE3

Panobinostat in Combination With Daratumumab, Bortezomib and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma

Status: TERMINATED
Phase: PHASE1

The Effect of Dilution and Prolonged Injection Time on Dexamethasone-induced Perineal Irritation

Status: UNKNOWN
Phase: NA

Selinexor in Combination With Immunomodulator （Thalidomide/Pomalidomide/Lenalidomide）in RRMM

Status: RECRUITING
Phase: PHASE2

Subcutaneous Daratumumab, Once Weekly Carfilzomib, and Dexamethasone (DKd) in Patients With High-Risk Smoldering Multiple Myeloma

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Personalized Selinexor-based Therapy for Relapsed/Refractory Multiple Myeloma

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

A Study of Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed by Cilta-cel, a CAR-T Therapy Directed Against BCMA Versus VRd Followed by Lenalidomide and Dexamethasone (Rd) Therapy in Participants With Newly Diagnosed Multiple Myeloma for Whom ASCT is Not Planned as Initial Therapy

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

GPED for Patients With Relapsed/Refractory or Advanced NK/T-cell Lymphoma

Status: UNKNOWN
Phase: PHASE2

Study to Evaluate Combined Treatment of Daratumumab, Bortezomib and Dexamethasone in PBL Patients.

Status: RECRUITING
Phase: PHASE2

Isatuximab, Velcade, and Dexamethasone in Patients With Multiple Myeloma and Severe KIDNEY Disease

Status: TERMINATED
Phase: PHASE1

Granisetron Transdermal Patch for Prophylaxis of Delayed CINV

Status: UNKNOWN
Phase: PHASE3

The DEPOT Study (Dry Eye Prescription Options for Therapy)

Status: COMPLETED
Phase: PHASE4

A Study Evaluating the Safety, Pharmacokinetics, and Activity of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1

Impact of Steroids on Inflammatory Response in Covid-19

Status: COMPLETED
Phase: PHASE3

Efficacy of Dexamethasone in Attenuation of Postinduction Hypotension in Geriatric Patients Undergoing General Anesthesia

Status: COMPLETED
Phase: PHASE4

Study of Pembrolizumab (MK-3475) Plus Docetaxel Versus Placebo Plus Docetaxel in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-921/KEYNOTE-921)-China Extension

Status: TERMINATED
Phase: PHASE3

Pre-emptive Dexamethasone in Hip Arthroplasty

Status: COMPLETED
Phase: NA

Radiosurgery Before Surgery for the Treatment of Brain Metastases

Status: COMPLETED
Phase: EARLY_PHASE1

Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Lemzoparlimab With or Without Oral/IV Dexamethasone and in Combination With Oral/IV/Subcutaneous Anti-Myeloma Regimens in Adult Participants With Multiple Myeloma

Status: TERMINATED
Phase: PHASE1